|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
There are very few studies on CLABSI in NNICU. Surveillance of CLABSI in NNICU is integral, as it provides insight to health care workers to work towards declining its rate and its unsavory consequences, via implementation and adherence to specific care bundles. Objectives of the study are: 1) To find the incidence of CLABSI in NNICU patients; 2) To identify etiological agents responsible for CLABSI; 3) To determine antimicrobial susceptibility pattern for bacterial agents obtained. Paired specimens, namely, distal end of central line and peripheral venous blood from suspected cases of CLABSI were subjected to culture and sensitivity test. Diagnosis of CLABSI was made when same strain of bacterium was obtained from both specimens along with significant bacterial count from catheter tip. Central line was inserted in 75 patients during the study period with 433 central line (CL) days with an average of 12-16 CL days per patient. 9(12%) out of 25 patients suspected of CLABSI yielded positive cultures. The CLABSI rate was 20.8 per 1000 central line days. The central line utilization rate was 0.3. E coli was the most predominant pathogen, followed by CoNS and Enterobacter. Most effective antimicrobial agents for Enterobacteriaciae group were colistin, gentamicin, imipenam and meropenam. CoNS and Pseudomonas were susceptible to all antimicrobial agents tested including simple ones, namely, ampicillin and cefipime respectively.